Reaction Details Report a problem with these data
Target
Nucleoprotein
Ligand
BDBM614530
Substrate
n/a
Meas. Tech.
TBD
EC50
52.0±n/a nM
Citation
 BARRETT, M; COCKERILL, GS; GOOD, J; AVERY, CA; COCHRANE, EJ; JONES, SP; ONIONS, ST; WARNER, AJ BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION US Patent  US20230270751 Publication Date 8/31/2023 
Target
Name:
Nucleoprotein
Synonyms:
N | NCAP_HRSVA | Nucleocapsid protein | Protein N
Type:
PROTEIN
Mol. Mass.:
43455.45
Organism:
Human respiratory syncytial virus A (strain A2)
Description:
ChEMBL_117398
Residue:
391
Sequence:
MALSKVKLNDTLNKDQLLSSSKYTIQRSTGDSIDTPNYDVQKHINKLCGMLLITEDANHKFTGLIGMLYAMSRLGREDTIKILRDAGYHVKANGVDVTTHRQDINGKEMKFEVLTLASLTTEIQINIEIESRKSYKKMLKEMGEVAPEYRHDSPDCGMIILCIAALVITKLAAGDRSGLTAVIRRANNVLKNEMKRYKGLLPKDIANSFYEVFEKHPHFIDVFVHFGIAQSSTRGGSRVEGIFAGLFMNAYGAGQVMLRWGVLAKSVKNIMLGHASVQAEMEQVVEVYEYAQKLGGEAGFYHILNNPKASLLSLTQFPHFSSVVLGNAAGLGIMGEYRGTPRNQDLYDAAKAYAEQLKENGVINYSVLDLTAEELEAIKHQLNPKDNDVEL
  
Inhibitor
Name:
BDBM614530
Synonyms:
2-(6-Ethylpyridin-3- yl)-N-[(3S)-9-fluoro- 2-oxo-5-phenyl-1,3- dihydro-1,4- benzodiazepin-3-yl]- 6,7-dihydro-5H- pyrazolo[5,1- b][1,3]oxazine-3- carboxamide | US20230270751, Example 106 | US20230270751, Example 106, BSA | US20230270751, Example 106, H2SO4 | US20230270751, Example 106, HCl | US20230270751, Example 106, MSA | US20230270751, Example 106, pTsSA
Type:
Small organic molecule
Emp. Form.:
C29H25FN6O3
Mol. Mass.:
524.5456
SMILES:
CCc1ccc(cn1)-c1nn2CCCOc2c1C(=O)N[C@H]1N=C(c2ccccc2)c2cccc(F)c2NC1=O |t:24|
Structure:
Search PDB for entries with ligand similarity: